Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Witnesses tell Ways and Means hearing early‑detection tests show promise but raise access and cost questions
Summary
Executives and clinicians at a House Ways and Means Health Subcommittee hearing described pilot use of multi‑cancer early detection tests and insurer incentive programs, saying the technologies can find cancers earlier but that Medicare coverage, cost and false positives remain barriers to broad access.
Brooks Tingle, chief executive officer of John Hancock, and Jay Carlson, a gynecologic oncologist and clinical chair at Mercy’s research arm, told a House Ways and Means Health Subcommittee hearing that multi‑cancer early detection (MCED) tests and insurer incentive programs can advance prevention and early diagnosis — but questions remain about Medicare reimbursement, access and downstream costs.
Tingle described John Hancock’s decade‑long Vitality wellness program, which uses app‑based incentives and partner discounts to encourage healthier behavior. “We introduced John Hancock Vitality, a program rooted in behavioral science that offers our life insurance customers tools, resources, incentives, and rewards to help improve their long term health,” Tingle said. He said the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
